Literature DB >> 18606713

Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.

Nienke Vrisekoop1, Rogier van Gent, Anne Bregje de Boer, Sigrid A Otto, Jan C C Borleffs, Radjin Steingrover, Jan M Prins, Taco W Kuijpers, Tom F W Wolfs, Sibyl P M Geelen, Irma Vulto, Peter Lansdorp, Kiki Tesselaar, José A M Borghans, Frank Miedema.   

Abstract

It remains uncertain whether full T cell reconstitution can be established in HIV-infected children and adults with long-term sustained virological control by highly active antiretroviral therapy (HAART). In this study, we comprehensively analyzed various phenotypical markers of CD4 T cell recovery. In addition to measuring T cell activation and proliferation markers, CD4 T cell generation and aging of the CD4 T cell compartment were assessed by measuring TCR excision circles and the fraction of CD31-expressing naive CD4 T cells. In all children and in adults with relatively high CD4 T cell counts at start of therapy (>200 cells/microl), total CD4 T cell numbers normalized within 1 year of therapy. After long-term HAART (4.4-9.6 years), naive CD4 T cell counts had normalized in both groups. Although in adults with low baseline CD4 T cell counts (<200 cells/microl) total CD4 T cell numbers normalized eventually after at least 7 years of HAART, naive CD4 T cell counts had still not recovered. TCR excision circle data showed that thymic T cell production contributed to naive T cell recovery at all ages. The fraction of CD31-expressing naive CD4 T cells was found to be normal, suggesting that the CD4 T cell repertoire was diverse after long-term HAART. Hence, under sustained viral suppression during long-term HAART, the T cell compartment has the potential to fully recover by generating new naive T cells both in children and in adults with high baseline CD4 T cells counts. Irrespective of baseline CD4 T cell counts, reconstitution occurred without a significant effect on T cell aging as reflected by markers for replicative history.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606713     DOI: 10.4049/jimmunol.181.2.1573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Role of collagen deposition in lymphatic tissues and immune reconstruction during HIV-1 and SIV infections.

Authors:  Jacob D Estes
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

2.  Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial.

Authors:  Berta Torres; Norma I Rallón; Montserrat Loncá; Alba Díaz; Llucia Alós; Esteban Martínez; Anna Cruceta; Joan Albert Arnaiz; Lorna Leal; Constanza Lucero; Agathe León; Marcelo Sánchez; Eugenia Negredo; Bonaventura Clotet; José M Gatell; José M Benito; Felipe Garcia
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-10       Impact factor: 2.205

3.  Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.

Authors:  Kellie N Smith; Robbie B Mailliard; Charles R Rinaldo
Journal:  For Immunopathol Dis Therap       Date:  2015

4.  IL-7-dependent STAT1 activation limits homeostatic CD4+ T cell expansion.

Authors:  Cecile Le Saout; Megan A Luckey; Alejandro V Villarino; Mindy Smith; Rebecca B Hasley; Timothy G Myers; Hiromi Imamichi; Jung-Hyun Park; John J O'Shea; H Clifford Lane; Marta Catalfamo
Journal:  JCI Insight       Date:  2017-11-16

5.  Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.

Authors:  Kristjana H Ásbjörnsdóttir; James P Hughes; Dalton Wamalwa; Agnes Langat; Jennifer A Slyker; Hellen M Okinyi; Julie Overbaugh; Sarah Benki-Nugent; Kenneth Tapia; Elizabeth Maleche-Obimbo; Ali Rowhani-Rahbar; Grace John-Stewart
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

6.  CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.

Authors:  Marta Catalfamo; Christopher Wilhelm; Lueng Tcheung; Michael Proschan; Travis Friesen; Jung-Hyun Park; Joseph Adelsberger; Michael Baseler; Frank Maldarelli; Richard Davey; Gregg Roby; Catherine Rehm; Clifford Lane
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

7.  Replication-independent expression of anti-apoptosis marker genes in human peripheral blood mononuclear cells infected with the wild-type HIV-1 and reverse transcriptase variants.

Authors:  Prem L Sharma; Himabindu Chunduri; Jasen Wise; Rondeen Mindley; David Rimland
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

8.  HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

Authors:  Delphine Sauce; Martin Larsen; Solène Fastenackels; Michèle Pauchard; Hocine Ait-Mohand; Luminita Schneider; Amélie Guihot; Faroudy Boufassa; John Zaunders; Malika Iguertsira; Michelle Bailey; Guy Gorochov; Claudine Duvivier; Guislaine Carcelain; Anthony D Kelleher; Anne Simon; Laurence Meyer; Dominique Costagliola; Steven G Deeks; Olivier Lambotte; Brigitte Autran; Peter W Hunt; Christine Katlama; Victor Appay
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

9.  Quantifying the development of the peripheral naive CD4+ T-cell pool in humans.

Authors:  Iren Bains; Rustom Antia; Robin Callard; Andrew J Yates
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

10.  Mid-ATR-FTIR spectroscopic profiling of HIV/AIDS sera for novel systems diagnostics in global health.

Authors:  Lungile Sitole; Francois Steffens; Tjaart P J Krüger; Debra Meyer
Journal:  OMICS       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.